Back to search

Sundara Pharmaceuticals Ltd

11636445

active
ltd
england wales
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

C/O Rmt Accountants & Business Advisors Ltd, Gosforth Park Avenue, Newcastle Upon Tyne, NE12 8EG
Incorporated 23/10/2018

Compliance

Last accounts

31/12/2025

total exemption full

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 14/10/2025

Due 28/10/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Samer Taslaq

director · Since 16/12/2020

British · England · Age 46

Former

Paul Watson

director · Resigned 15/05/2023

Persons with Significant Control

Dr Samer Taslaq

25–50% shares
25–50% votes

British · England · Age 46

C/O Rmt Accountants & Business Advisors Ltd, Gosforth Park Avenue, Newcastle Upon Tyne, NE12 8EG

Notified 08/12/2020

Former PSCs

Leslie Anderson

Ceased 08/12/2020

Change History

officer appointedTASLAQ, Samer, Dr
2026-06-06
statusactive
2026-06-06

Active

typeltd
2026-06-06

Private Limited Company

address line1C/O Rmt Accountants & Business Advisors Ltd
2026-06-06

C/O RMT ACCOUNTANTS & BUSINESS ADVISORS LTD

post townNewcastle Upon Tyne
2026-06-06

NEWCASTLE UPON TYNE

CompanyRankvs 1136+ SIC 72110 peers
50

Financial strength39th percentile among SIC peers · 10/25
Employees47th percentile among SIC peers · 7/15
LiquidityCurrent ratio 18.56× · 20/20
Longevity8 years trading (max 15) · 8/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength10/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees7/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity8/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

er, the director is aware of certain material uncertainties which may cause doubt on the company's ability to continue as a going concern. 1.3 Research and development expenditure Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent th

Key FinancialsYear ending 31/12/2025

Net Worth

£85

Balance sheet strength

Cash

£108k

Cash in the bank

Net Current Assets

£102k

Working capital

Current Assets

£108k

Current Liabilities

£6k

Debtors

£7

1avg. employees-1

Balance Sheet

Intangible assets£45k
Assets less current liabilities£147k
Prepared with CCH Software

EstimatesDerived

YearCurrent Ratio
202518.56
20230.98
202220.25
202122.19
202045.88

Derived from filed accounts. Not audited figures.